- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8556
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,556 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
3DA | AU$0.39 | 11.4% | 100.0% | AU$211.9m | n/a | PS456.8x | E59.4% | n/a | Capital Goods | ||
AFISH | NOK 48.00 | 2.1% | -46.4% | NOK 1.5b | NOK 81.00 | PS1.5x | E98.9% | n/a | Food, Beverage & Tobacco | ||
GGP | UK£0.071 | 14.1% | 16.4% | UK£361.4m | n/a | PB7.2x | E48.8% | n/a | Materials | ||
TGTX | US$23.33 | -7.7% | 166.0% | US$3.3b | US$33.75 | PE35x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.37 | -0.4% | 61.9% | ج.م28.5b | ج.م11.44 | PE29.6x | E29.4% | n/a | Diversified Financials | ||
ARES | US$156.05 | -0.3% | 48.8% | US$49.5b | US$150.23 | PE82.4x | E32.9% | 2.4% | Diversified Financials | ||
TVTX | US$15.04 | -0.1% | 67.5% | US$1.1b | US$17.60 | PS6.5x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
MBTN | CHF 1.59 | -3.2% | -99.4% | CHF 49.0m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
RHM | €484.30 | -1.9% | 92.4% | €21.0b | €616.44 | PE32.3x | E27.7% | 1.2% | Capital Goods | ||
AXSM | US$89.64 | -5.0% | 22.7% | US$4.3b | US$125.24 | PS14.8x | E68.9% | n/a | Pharmaceuticals & Biotech | ||
SCOL | SEK 0.15 | 4.2% | -90.2% | SEK 34.8m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.23 | 9.1% | 4.4% | SEK 333.0m | SEK 2.20 | PS2.9x | E86.1% | n/a | Tech | ||
NEWBRY | SEK 3.30 | 11.5% | -8.1% | SEK 80.1m | SEK 8.00 | PS4.3x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
LAVV3 | R$8.08 | -2.5% | 7.0% | R$1.6b | R$12.98 | PE5.8x | E21.1% | 3.5% | Real Estate Management and Development | ||
CADLR | NOK 72.80 | 3.1% | 98.4% | NOK 25.5b | NOK 81.94 | PS17.6x | E67.8% | n/a | Capital Goods | ||
ZVRA | US$7.31 | -8.9% | 47.5% | US$397.0m | US$20.50 | PS16.2x | E68.5% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$51.57 | 3.7% | 96.6% | US$16.1b | US$50.32 | PE90.6x | E24.2% | n/a | Consumer Durables | ||
AGP | €7.04 | 5.1% | 60.4% | €121.9m | €12.75 | PE18x | E22.1% | n/a | Capital Goods | ||
AESI | US$21.28 | -4.5% | -7.8% | US$2.5b | US$26.00 | PE16x | E42.1% | 4.3% | Energy | ||
CALTX | SEK 206.40 | 0.1% | 110.9% | SEK 11.2b | SEK 227.50 | PS7x | E50.4% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$31.23 | 7.8% | 107.9% | US$5.0b | US$35.33 | PS23.8x | E95.0% | n/a | Semiconductors | ||
RMDA | ج.م2.75 | 3.8% | 92.2% | ج.م4.1b | ج.م4.11 | PE18.2x | E30.2% | 2.4% | Pharmaceuticals & Biotech | ||
7373 | JP¥1,583.00 | 3.1% | -27.2% | JP¥23.9b | JP¥4,600.00 | PE24x | E32.7% | 1.9% | Commercial Services | ||
EH | US$13.85 | 11.9% | -22.4% | US$802.5m | US$24.35 | PS24.7x | E81.4% | n/a | Capital Goods |